{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:40:50Z","timestamp":1788921650915,"version":"build-2803163510"},"reference-count":166,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.semnephrol.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T08:30:18Z","timestamp":1509093018000},"page":"490-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story"],"prefix":"10.1016","volume":"37","author":[{"given":"Etty","family":"Kruzel-Davila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter G.","family":"Wasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Skorecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2017.07.002_bib1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2015.230","article-title":"A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010","volume":"88","author":"Mills","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib4","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib6","series-title":"USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States","year":"2015"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib7","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2013.03.009","article-title":"Lifetime incidence of CKD stages 3-5 in the United States","volume":"62","author":"Grams","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib9","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1097\/01.ASN.0000138546.53152.A7","article-title":"Is there an epidemic of HIV infection in the US ESRD program?","volume":"15","author":"Eggers","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1086\/587994","article-title":"Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races","volume":"197","author":"Lucas","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0272-6386(12)80266-6","article-title":"The familial risk of end-stage renal disease in African Americans","volume":"21","author":"Freedman","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib12","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1681\/ASN.V8121942","article-title":"Family history of end-stage renal disease among incident dialysis patients","volume":"8","author":"Freedman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jama.1997.03540400043029","article-title":"End-stage renal disease in African-American and white men. 16-year MRFIT findings","volume":"277","author":"Klag","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib14","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/01.ASN.0000026493.18542.6A","article-title":"Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors","volume":"13","author":"Tarver-Carr","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archinte.1995.00430110121013","article-title":"Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors","volume":"155","author":"Perneger","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2012070659","article-title":"Segregation, income disparities, and survival in hemodialysis patients","volume":"24","author":"Kimmel","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1681\/ASN.V971270","article-title":"Familial aggregation of renal disease in a population-based case-control study","volume":"9","author":"Lei","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrg1839","article-title":"Family-based designs in the age of large-scale gene-association studies","volume":"7","author":"Laird","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrg3523","article-title":"Bringing genome-wide association findings into clinical use","volume":"14","author":"Manolio","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1101\/gr.190603.115","article-title":"Genomic approaches for understanding the genetics of complex disease","volume":"25","author":"Lowe","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib23","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1073\/pnas.85.23.9119","article-title":"Admixture as a tool for finding linked genes and detecting that difference from allelic association between loci","volume":"85","author":"Chakraborty","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib24","first-page":"809","article-title":"Mapping by admixture linkage disequilibrium in human populations: limits and guidelines","volume":"55","author":"Stephens","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/301908","article-title":"Mapping genes that underlie ethnic differences in disease risk: methods for detecting linkage in admixed populations, by conditioning on parental admixture","volume":"63","author":"McKeigue","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrg1657","article-title":"Mapping by admixture linkage disequilibrium: advances, limitations and guidelines","volume":"6","author":"Smith","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1755-8794-3-47","article-title":"Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers","volume":"3","author":"Shlush","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/msj.20172","article-title":"Is there a genetic basis for health disparities in human immunodeficiency virus disease?","volume":"77","author":"Winkler","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1126\/science.1183863","article-title":"A composite of multiple signals distinguishes causal variants in regions of positive selection","volume":"327","author":"Grossman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib30","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1371\/journal.pbio.0040072","article-title":"A map of recent positive selection in the human genome","volume":"4","author":"Voight","year":"2006","journal-title":"PLoS Biol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib31","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2010.251","article-title":"A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9","volume":"78","author":"Genovese","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib35","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib36","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI46263","article-title":"Genetics of kidney failure and the evolving story of APOL1","volume":"121","author":"Friedman","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib37","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.semnephrol.2015.04.008","article-title":"APOL1 kidney disease risk variants: an evolving landscape","volume":"35","author":"Dummer","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrg3118","article-title":"Rare and common variants: twenty arguments","volume":"13","author":"Gibson","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0035-9203(54)90101-7","article-title":"The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria","volume":"48","author":"Allison","year":"1954","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.1213775","article-title":"Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes","volume":"334","author":"Cyrklaff","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib42","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2011040434","article-title":"APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy","volume":"22","author":"Papeta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib44","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib45","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib47","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1681\/ASN.2015020124","article-title":"APOL1 genotype and race differences in incident albuminuria and renal function decline","volume":"27","author":"Peralta","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib49","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","author":"Grams","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5301\/jn.5000179","article-title":"Population genetics of chronic kidney disease: the evolving story of APOL1","volume":"25","author":"Wasser","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000353223","article-title":"High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria","volume":"123","author":"Ulasi","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11255-012-0263-4","article-title":"Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians","volume":"45","author":"Tayo","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajhg.2013.05.014","article-title":"Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations","volume":"93","author":"Ko","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib54","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nature01140","article-title":"Detecting recent positive selection in the human genome from haplotype structure","volume":"419","author":"Sabeti","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature06250","article-title":"Genome-wide detection and characterization of positive selection in human populations","volume":"449","author":"Sabeti","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2015.151","article-title":"Sequencing rare and common APOL1 coding variants to determine kidney disease risk","volume":"88","author":"Limou","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib57","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature09298","article-title":"Integrating common and rare genetic variation in diverse human populations","volume":"467","author":"Altshuler","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/519221","article-title":"Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants","volume":"81","author":"Ayodo","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib60","doi-asserted-by":"crossref","first-page":"e0160413","DOI":"10.1371\/journal.pone.0160413","article-title":"On the apportionment of population structure","volume":"11","author":"Granot","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/geno.2002.6729","article-title":"The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue","volume":"79","author":"Monajemi","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib64","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature04072","article-title":"Initial sequence of the chimpanzee genome and comparison with the human genome","volume":"437","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib66","doi-asserted-by":"crossref","first-page":"25576","DOI":"10.1074\/jbc.272.41.25576","article-title":"Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L","volume":"272","author":"Duchateau","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/geno.2001.6534","article-title":"The human apolipoprotein L gene cluster: identification, classification, and sites of distribution","volume":"74","author":"Page","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib68","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00018-006-6091-x","article-title":"The function of apolipoproteins L","volume":"63","author":"Vanhollebeke","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib69","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/S0021-9258(18)83720-6","article-title":"Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein","volume":"264","author":"Hajduk","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1194\/jlr.M063453","article-title":"Characterization of circulating APOL1 protein complexes in African Americans","volume":"57","author":"Weckerle","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib71","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/IAI.67.4.1910-1916.1999","article-title":"Characterization of a novel trypanosome lytic factor from human serum","volume":"67","author":"Raper","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib72","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1073\/pnas.0609902104","article-title":"Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum","volume":"104","author":"Vanhollebeke","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib73","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.20071463","article-title":"Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model","volume":"205","author":"Molina-Portela","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib74","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrmicro1428","article-title":"The trypanolytic factor of human serum","volume":"4","author":"Pays","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib75","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib76","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib77","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/EC.05112-11","article-title":"Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity","volume":"10","author":"Stephens","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib78","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/cmi.12454","article-title":"Localization of serum resistance-associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei","volume":"17","author":"Bart","year":"2015","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib79","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/ncomms9078","article-title":"Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1","volume":"6","author":"Vanwalleghem","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","article-title":"A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense","volume":"95","author":"Xong","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib81","doi-asserted-by":"crossref","first-page":"e25461","DOI":"10.7554\/eLife.25461","article-title":"APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis","volume":"6","author":"Cooper","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib82","first-page":"e29056","article-title":"Gene variation: the double-edged sword of evolution","volume":"6","author":"Kruzel-Davila","year":"2017","journal-title":"e LIFE"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib83","doi-asserted-by":"crossref","first-page":"e1000276","DOI":"10.1371\/journal.ppat.1000276","article-title":"Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection","volume":"5","author":"Samanovic","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib84","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib85","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection","volume":"88","author":"Taylor","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12977-015-0165-5","article-title":"Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses","volume":"12","author":"McLaren","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib87","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jid.2015.12.006","article-title":"Interferon-? protects from Staphylococcal alpha toxin-induced keratinocyte death through apolipoprotein L1","volume":"136","author":"Brauweiler","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrneph.2013.34","article-title":"APOL1 variants and kidney disease in people of recent African ancestry","volume":"9","author":"Genovese","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib89","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/420856","article-title":"A high-density admixture map for disease gene discovery in African Americans","volume":"74","author":"Smith","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib90","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000332378","article-title":"Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population","volume":"34","author":"Behar","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrneph.2011.52","article-title":"The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus","volume":"7","author":"Rosset","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib92","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2012.111","article-title":"HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics","volume":"82","author":"Atta","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib93","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/ndt\/gfq768","article-title":"Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese","volume":"26","author":"Cheng","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib94","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfr522","article-title":"Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans","volume":"27","author":"Cooke","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib95","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/hmg\/ddr118","article-title":"The MYH9\/APOL1 region and chronic kidney disease in European-Americans","volume":"20","author":"O'Seaghdha","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib96","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1681\/ASN.2014050444","article-title":"Lack of association of the APOL1 G3 haplotype in African Americans with ESRD","volume":"26","author":"Palmer","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000439448","article-title":"Re-sequencing of the APOL1-APOL4 and MYH9 gene regions in African Americans does not identify additional risks for CKD progression","volume":"42","author":"Hawkins","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib98","doi-asserted-by":"crossref","unstructured":"Skorecki KL, Lee JH, Langefeld CD, et al. A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Nephrol Dial Transplant. 2017 Feb 20. http:\/\/dx.doi.org\/10.1093\/ndt\/gfw451. [Epub ahead of print].","DOI":"10.1093\/ndt\/gfw451"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib99","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","article-title":"Genetic variation in APOL1 associates with younger age at hemodialysis initiation","volume":"22","author":"Kanji","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib100","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib101","doi-asserted-by":"crossref","first-page":"e0125410","DOI":"10.1371\/journal.pone.0125410","article-title":"Copy number variation at the APOL1 locus","volume":"10","author":"Ruchi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molbiopara.2003.11.006","article-title":"Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera","volume":"134","author":"Poelvoorde","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib103","doi-asserted-by":"crossref","first-page":"e51546","DOI":"10.1371\/journal.pone.0051546","article-title":"APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib104","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yexmp.2015.06.003","article-title":"Protein domains of APOL1 and its risk variants","volume":"99","author":"Lan","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib106","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yexmp.2015.03.020","article-title":"Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu","volume":"98","author":"Lan","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib107","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.M059733","article-title":"Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells","volume":"56","author":"Cheng","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib108","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1152\/ajpcell.00384.2014","article-title":"Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1","volume":"309","author":"Khatua","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib109","doi-asserted-by":"crossref","first-page":"C332","DOI":"10.1152\/ajpcell.00142.2015","article-title":"BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins","volume":"309","author":"Heneghan","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib110","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4161\/auto.7066","article-title":"ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death","volume":"4","author":"Zhaorigetu","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib111","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ki.2015.109","article-title":"APOL1 toxin, innate immunity, and kidney injury","volume":"88","author":"Limou","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib112","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.ajkd.2011.09.020","article-title":"Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy","volume":"59","author":"Bostrom","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib113","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ndt\/gft423","article-title":"Gene-gene interactions in APOL1-associated nephropathy","volume":"29","author":"Divers","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib114","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1681\/ASN.2015050487","article-title":"Combined effects of GSTM1 null allele and APOL1 renal risk alleles in CKD progression in the African American Study of Kidney Disease and Hypertension Trial","volume":"27","author":"Bodonyi-Kovacs","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib115","doi-asserted-by":"crossref","first-page":"F348","DOI":"10.1152\/ajprenal.00568.2012","article-title":"Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK)","volume":"304","author":"Chang","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib116","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1074\/jbc.M115.680371","article-title":"Trypanosome lytic factor-1 initiates oxidation-stimulated osmotic lysis of Trypanosoma brucei brucei","volume":"291","author":"Greene","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib117","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ki.2013.203","article-title":"Host APOL1 genotype is independently associated with proteinuria in HIV infection","volume":"84","author":"Estrella","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib118","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","article-title":"Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy","volume":"59","author":"Moudgil","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib119","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0272-6386(00)70055-2","article-title":"Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis","volume":"35","author":"Tanawattanacharoen","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib120","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ki.2013.173","article-title":"JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy","volume":"84","author":"Divers","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cell.2011.09.009","article-title":"Metagenomics and personalized medicine","volume":"147","author":"Virgin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib122","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfu391","article-title":"APOL1 nephropathy: from gene to mechanisms of kidney injury","volume":"31","author":"Kruzel-Davila","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib123","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib124","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/j.ajkd.2014.02.024","article-title":"Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy","volume":"64","author":"Larsen","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib127","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical features and histology of apolipoprotein l1-associated nephropathy in the FSGS clinical trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib128","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2014111131","article-title":"Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects","volume":"27","author":"Sampson","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib129","doi-asserted-by":"crossref","first-page":"21540","DOI":"10.1074\/jbc.M800214200","article-title":"Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death","volume":"283","author":"Wan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semnephrol.2013.11.003","article-title":"Autophagy: emerging therapeutic target for diabetic nephropathy","volume":"34","author":"Kume","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib131","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib132","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2215\/CJN.05220515","article-title":"Examination of potential modifiers of the association of APOL1 alleles with CKD progression","volume":"10","author":"Chen","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib133","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib134","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib136","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2215\/CJN.08340814","article-title":"Hemostatic factors, APOL1 risk variants, and the risk of ESRD in the Atherosclerosis Risk in Communities Study","volume":"10","author":"Tin","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib137","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2014.255","article-title":"APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes","volume":"87","author":"Freedman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib138","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2014.254","article-title":"Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial","volume":"87","author":"Langefeld","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib139","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.kint.2016.04.027","article-title":"APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume","volume":"90","author":"Freedman","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.kint.2016.02.032","article-title":"APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease","volume":"90","author":"Ma","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib141","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.kint.2016.03.024","article-title":"APOL1 risk variants and death among African American hemodialysis patients: survival of the fittest?","volume":"90","author":"Chen","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib142","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1681\/ASN.2007070747","article-title":"Racial differences in mortality among those with CKD","volume":"19","author":"Mehrotra","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib143","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.2016040441","article-title":"Most ApoL1 is secreted by the liver","volume":"28","author":"Shukha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib144","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1681\/ASN.2013070700","article-title":"Plasma apolipoprotein L1 levels do not correlate with CKD","volume":"25","author":"Bruggeman","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib145","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1681\/ASN.2015101121","article-title":"Plasma levels of risk-variant APOL1 do not associate with renal disease in a population-based cohort","volume":"27","author":"Kozlitina","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib146","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib147","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib148","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","author":"Freedman","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib149","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.tp.0000277288.78771.c2","article-title":"Living kidney donors requiring transplantation: focus on African Americans","volume":"84","author":"Gibney","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib151","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among living kidney donors","volume":"363","author":"Lentine","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib152","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib153","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1526924816654608","article-title":"Introducing genetic tests with uncertain implications in living donor kidney transplantation: ApoL1 as a case study","volume":"26","author":"Ross","year":"2016","journal-title":"Prog Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib154","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2015.04.046","article-title":"Testing for high-risk APOL1 alleles in potential living kidney donors","volume":"66","author":"Riella","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib155","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfl337","article-title":"Antiretroviral therapy in the treatment of HIV-associated nephropathy","volume":"21","author":"Atta","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib156","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/cid\/ciu617","article-title":"Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"59","author":"Lucas","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib157","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/cid\/ciu765","article-title":"The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status","volume":"60","author":"Estrella","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib158","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib159","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.2016111262","article-title":"Identifying the intracellular function of APOL1","volume":"28","author":"Bruggeman","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib160","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2016050567","article-title":"APOL1 renal-risk variants induce mitochondrial dysfunction","volume":"28","author":"Ma","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib161","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.2016050550","article-title":"APOL1-G1 in nephrocytes induces hypertrophy and accelerates cell death","volume":"28","author":"Fu","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib162","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2016050546","article-title":"APOL1-mediated cell injury involves disruption of conserved trafficking processes","volume":"28","author":"Kruzel-Davila","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib163","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib164","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/febs.13706","article-title":"Structural characterization of the C-terminal coiled coil domains of wild-type and kidney disease associated mutants of apolipoprotein L1","volume":"283","author":"Sharma","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.semnephrol.2017.07.002_bib166","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09792","article-title":"Initial impact of the sequencing of the human genome","volume":"470","author":"Lander","year":"2011","journal-title":"Nature"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T17:47:09Z","timestamp":1659721629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929517300682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":166,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0270929517300682"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.07.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}